Global Antibody-drug Conjugates Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Antibody-drug Conjugates market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9% in the forecast period of 2020 to 2025 and will expected to reach USD 3049.2 million by 2025, from USD 2722.8 million in 2019.
The Antibody-drug Conjugates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antibody-drug Conjugates market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antibody-drug Conjugates market has been segmented into Adcetris, Kadcyla, etc.
By Application, Antibody-drug Conjugates has been segmented into Breast Cancer, Lymphoma, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibody-drug Conjugates market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibody-drug Conjugates markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibody-drug Conjugates market.
The report offers in-depth assessment of the growth and other aspects of the Antibody-drug Conjugates market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Antibody-drug Conjugates markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Antibody-drug Conjugates Market Share Analysis
Antibody-drug Conjugates competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antibody-drug Conjugates sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibody-drug Conjugates sales, revenue and market share for each player covered in this report.
The major players covered in Antibody-drug Conjugates are: ImmunoGen, Takeda, Seattle Genetics, Roche, etc. Among other players domestic and global, Antibody-drug Conjugates market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugates product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugates, with price, sales, revenue and global market share of Antibody-drug Conjugates in 2018 and 2019.
Chapter 3, the Antibody-drug Conjugates competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugates breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antibody-drug Conjugates market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antibody-drug Conjugates sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antibody-drug Conjugates Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody-drug Conjugates Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody-drug Conjugates Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Overview of Global Antibody-drug Conjugates Market
1.4.1 Global Antibody-drug Conjugates Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ImmunoGen
2.1.1 ImmunoGen Details
2.1.2 ImmunoGen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 ImmunoGen SWOT Analysis
2.1.4 ImmunoGen Product and Services
2.1.5 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Seattle Genetics
2.3.1 Seattle Genetics Details
2.3.2 Seattle Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Seattle Genetics SWOT Analysis
2.3.4 Seattle Genetics Product and Services
2.3.5 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antibody-drug Conjugates Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antibody-drug Conjugates Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2019
3.3.2 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antibody-drug Conjugates Sales, Revenue and Market Share by Regions
4.1.1 Global Antibody-drug Conjugates Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antibody-drug Conjugates Revenue and Market Share by Regions (2015-2020)
4.2 North America Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
4.3 Europe Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
4.5 South America Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antibody-drug Conjugates Sales, Revenue and Market Share by Country
5.1.1 North America Antibody-drug Conjugates Sales and Market Share by Country (2015-2020)
5.1.2 North America Antibody-drug Conjugates Revenue and Market Share by Country (2015-2020)
5.2 United States Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
5.3 Canada Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
5.4 Mexico Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antibody-drug Conjugates Sales, Revenue and Market Share by Country
6.1.1 Europe Antibody-drug Conjugates Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antibody-drug Conjugates Revenue and Market Share by Country (2015-2020)
6.2 Germany Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
6.3 UK Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
6.4 France Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
6.5 Russia Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
6.6 Italy Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antibody-drug Conjugates Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antibody-drug Conjugates Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antibody-drug Conjugates Revenue and Market Share by Regions (2015-2020)
7.2 China Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
7.3 Japan Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
7.4 Korea Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
7.5 India Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
7.7 Australia Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antibody-drug Conjugates Sales, Revenue and Market Share by Country
8.1.1 South America Antibody-drug Conjugates Sales and Market Share by Country (2015-2020)
8.1.2 South America Antibody-drug Conjugates Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
8.3 Argentina Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antibody-drug Conjugates Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antibody-drug Conjugates Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antibody-drug Conjugates Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
9.3 Turkey Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
9.4 Egypt Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
9.5 South Africa Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antibody-drug Conjugates Sales and Market Share by Type (2015-2020)
10.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2015-2020)
10.3 Global Antibody-drug Conjugates Price by Type (2015-2020)
11 Global Antibody-drug Conjugates Market Segment by Application
11.1 Global Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
11.2 Global Antibody-drug Conjugates Revenue Market Share by Application (2015-2020)
11.3 Global Antibody-drug Conjugates Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antibody-drug Conjugates Sales, Revenue and Growth Rate (2021-2025)
12.2 Antibody-drug Conjugates Market Forecast by Regions (2021-2025)
12.2.1 North America Antibody-drug Conjugates Market Forecast (2021-2025)
12.2.2 Europe Antibody-drug Conjugates Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antibody-drug Conjugates Market Forecast (2021-2025)
12.2.4 South America Antibody-drug Conjugates Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antibody-drug Conjugates Market Forecast (2021-2025)
12.3 Antibody-drug Conjugates Market Forecast by Type (2021-2025)
12.3.1 Global Antibody-drug Conjugates Sales Forecast by Type (2021-2025)
12.3.2 Global Antibody-drug Conjugates Market Share Forecast by Type (2021-2025)
12.4 Antibody-drug Conjugates Market Forecast by Application (2021-2025)
12.4.1 Global Antibody-drug Conjugates Sales Forecast by Application (2021-2025)
12.4.2 Global Antibody-drug Conjugates Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Antibody-drug Conjugates Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibody-drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibody-drug Conjugates Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 8. ImmunoGen Antibody-drug Conjugates Major Business
Table 9. ImmunoGen Antibody-drug Conjugates Total Revenue (USD Million) (2017-2018)
Table 10. ImmunoGen SWOT Analysis
Table 11. ImmunoGen Antibody-drug Conjugates Product and Services
Table 12. ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Takeda Basic Information, Manufacturing Base and Competitors
Table 14. Takeda Antibody-drug Conjugates Major Business
Table 15. Takeda Antibody-drug Conjugates Total Revenue (USD Million) (2017-2018)
Table 16. Takeda SWOT Analysis
Table 17. Takeda Antibody-drug Conjugates Product and Services
Table 18. Takeda Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Seattle Genetics Basic Information, Manufacturing Base and Competitors
Table 20. Seattle Genetics Antibody-drug Conjugates Major Business
Table 21. Seattle Genetics Antibody-drug Conjugates Total Revenue (USD Million) (2017-2018)
Table 22. Seattle Genetics SWOT Analysis
Table 23. Seattle Genetics Antibody-drug Conjugates Product and Services
Table 24. Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Roche Basic Information, Manufacturing Base and Competitors
Table 26. Roche Antibody-drug Conjugates Major Business
Table 27. Roche Antibody-drug Conjugates Total Revenue (USD Million) (2017-2018)
Table 28. Roche SWOT Analysis
Table 29. Roche Antibody-drug Conjugates Product and Services
Table 30. Roche Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Antibody-drug Conjugates Sales by Manufacturer (2018-2019) (Kg)
Table 32. Global Antibody-drug Conjugates Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Antibody-drug Conjugates Sales by Regions (2015-2020) (Kg)
Table 34. Global Antibody-drug Conjugates Sales Market Share by Regions (2015-2020)
Table 35. Global Antibody-drug Conjugates Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 37. North America Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 38. North America Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 40. Europe Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 41. Europe Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 42. Europe Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Antibody-drug Conjugates Sales by Regions (2015-2020) (Kg)
Table 44. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Antibody-drug Conjugates Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 47. South America Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 48. South America Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Antibody-drug Conjugates Sales by Countries (2015-2020) (Kg)
Table 51. Middle East & Africa Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Antibody-drug Conjugates Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Table 54. Global Antibody-drug Conjugates Sales by Type (2015-2020) (Kg)
Table 55. Global Antibody-drug Conjugates Sales Share by Type (2015-2020)
Table 56. Global Antibody-drug Conjugates Revenue by Type (2015-2020) (USD Million)
Table 57. Global Antibody-drug Conjugates Revenue Share by Type (2015-2020)
Table 58. Global Antibody-drug Conjugates Sales by Application (2015-2020) (Kg)
Table 59. Global Antibody-drug Conjugates Sales Share by Application (2015-2020)
Table 60. Global Antibody-drug Conjugates Sales Forecast by Regions (2021-2025) (Kg)
Table 61. Global Antibody-drug Conjugates Market Share Forecast by Regions (2021-2025)
Table 62. Global Antibody-drug Conjugates Sales Forecast by Type (2021-2025) (Kg)
Table 63. Global Antibody-drug Conjugates Market Share Forecast by Type (2021-2025)
Table 64. Global Antibody-drug Conjugates Sales Forecast by Application (2021-2025)
Table 65. Global Antibody-drug Conjugates Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antibody-drug Conjugates Picture
Figure 2. Global Sales Market Share of Antibody-drug Conjugates by Type in 2019
Figure 3. Adcetris Picture
Figure 4. Kadcyla Picture
Figure 5. Antibody-drug Conjugates Sales Market Share by Application in 2018
Figure 6. Breast Cancer Picture
Figure 7. Lymphoma Picture
Figure 8. Global Antibody-drug Conjugates Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Antibody-drug Conjugates Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Antibody-drug Conjugates Sales Market Share by Manufacturer in 2019
Figure 29. Global Antibody-drug Conjugates Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Antibody-drug Conjugates Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 34. Global Antibody-drug Conjugates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Antibody-drug Conjugates Revenue Market Share by Regions (2015-2020)
Figure 36. Global Antibody-drug Conjugates Revenue Market Share by Regions in 2018
Figure 37. North America Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
Figure 38. Europe Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
Figure 40. South America Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Antibody-drug Conjugates Sales and Growth Rate (2015-2020)
Figure 42. North America Antibody-drug Conjugates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Antibody-drug Conjugates Sales Market Share by Countries (2015-2020)
Figure 44. North America Antibody-drug Conjugates Sales Market Share by Countries in 2018
Figure 45. North America Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Antibody-drug Conjugates Revenue Market Share by Countries in 2018
Figure 47. United States Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 48. Canada Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 49. Mexico Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 50. Europe Antibody-drug Conjugates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Antibody-drug Conjugates Revenue Market Share by Countries in 2019
Figure 53. Germany Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 54. UK Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 55. France Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 56. Russia Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 57. Italy Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 58. Asia-Pacific Antibody-drug Conjugates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Antibody-drug Conjugates Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Antibody-drug Conjugates Revenue Market Share by Regions 2019
Figure 61. China Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 62. Japan Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 63. Korea Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 64. India Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 65. Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 66. South America Antibody-drug Conjugates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Antibody-drug Conjugates Sales Market Share by Countries in 2019
Figure 68. South America Antibody-drug Conjugates Revenue Market Share by Countries in 2019
Figure 69. Brazil Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 70. Argentina Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 71. Middle East and Africa Antibody-drug Conjugates Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 76. Egypt Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 77. Turkey Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 78. South Africa Antibody-drug Conjugates Sales and Growth Rate (2015-2020) (Kg)
Figure 79. Global Antibody-drug Conjugates Sales and Growth Rate (2021-2025) (Kg)
Figure 80. Global Antibody-drug Conjugates Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Antibody-drug Conjugates Market Forecast (2021-2025) (Kg)
Figure 82. Europe Sales Antibody-drug Conjugates Market Forecast (2021-2025) (Kg)
Figure 83. Asia-Pacific Sales Antibody-drug Conjugates Market Forecast (2021-2025) (Kg)
Figure 84. South America Sales Antibody-drug Conjugates Market Forecast (2021-2025) (Kg)
Figure 85. Middle East & Africa Sales Antibody-drug Conjugates Market Forecast (2021-2025) (Kg)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets